Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | Celf5 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CELF5 mRNA | CTD | PMID:22206623 | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CELF5 mRNA | CTD | PMID:30723492 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Celf5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CELF5 mRNA | CTD | PMID:16962184 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CELF5 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CELF5 mRNA | CTD | PMID:32109520 | 4,4'-sulfonyldiphenol | decreases expression | ISO | Celf5 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of CELF5 mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Celf5 (Mus musculus) | 6480464 | bisphenol S affects the methylation of CELF5 gene | CTD | PMID:31683443 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of CELF5 mRNA | CTD | PMID:30047161 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of CELF5 mRNA | CTD | PMID:36843608 | 7,12-dimethyltetraphene | increases expression | ISO | Celf5 (Mus musculus) | 6480464 | 9 more ... | CTD | PMID:32553695 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of CELF5 mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases methylation | ISO | CELF5 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of CELF5 3' UTR and Aflatoxin B1 results in increased methylation of CELF5 intron | CTD | PMID:30157460 | Aflatoxin B2 alpha | increases methylation | ISO | CELF5 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of CELF5 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | CELF5 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CELF5 mRNA | CTD | PMID:21934132 | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of CELF5 mRNA | CTD | PMID:30047161 | benzo[a]pyrene | increases mutagenesis | ISO | CELF5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased mutagenesis of CELF5 gene | CTD | PMID:25435355 | benzo[a]pyrene | multiple interactions | ISO | Celf5 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CELF5 mRNA | CTD | PMID:27858113 | benzo[a]pyrene | increases expression | ISO | Celf5 (Mus musculus) | 6480464 | Benzo(a)pyrene metabolite results in increased expression of CELF5 mRNA and Benzo(a)pyrene results in increased expression of CELF5 mRNA | CTD | PMID:23735875 and PMID:32553695 | benzo[b]fluoranthene | increases expression | ISO | Celf5 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of CELF5 mRNA | CTD | PMID:26377693 | benzo[b]fluoranthene | multiple interactions | ISO | Celf5 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CELF5 mRNA | CTD | PMID:27858113 | benzo[e]pyrene | decreases methylation | ISO | CELF5 (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of CELF5 intron | CTD | PMID:30157460 | Benzo[ghi]perylene | decreases expression | ISO | Celf5 (Mus musculus) | 6480464 | 1 and 12-benzoperylene results in decreased expression of CELF5 mRNA | CTD | PMID:26377693 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CELF5 mRNA | CTD | PMID:25181051 and PMID:30816183 | bisphenol A | decreases expression | ISO | Celf5 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CELF5 mRNA | CTD | PMID:32156529 | bisphenol A | increases methylation | ISO | CELF5 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of CELF5 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | CELF5 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CELF5 gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CELF5 mRNA | CTD | PMID:34947998 | bisphenol F | decreases expression | ISO | Celf5 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of CELF5 mRNA | CTD | PMID:30951980 | butanal | increases expression | ISO | CELF5 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of CELF5 mRNA | CTD | PMID:26079696 | Butylparaben | increases expression | ISO | CELF5 (Homo sapiens) | 6480464 | butylparaben results in increased expression of CELF5 mRNA | CTD | PMID:17121429 | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of CELF5 mRNA | CTD | PMID:19167457 | cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of CELF5 promoter | CTD | PMID:22457795 | chlorpyrifos | decreases expression | ISO | Celf5 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of CELF5 mRNA | CTD | PMID:37019170 | chrysene | multiple interactions | ISO | Celf5 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CELF5 mRNA | CTD | PMID:27858113 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CELF5 mRNA | CTD | PMID:24386269 | copper atom | multiple interactions | EXP | | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of CELF5 mRNA | CTD | PMID:26033743 | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of CELF5 mRNA | CTD | PMID:26033743 | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of CELF5 mRNA | CTD | PMID:26033743 | copper(0) | multiple interactions | EXP | | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of CELF5 mRNA | CTD | PMID:26033743 | dibenz[a,h]anthracene | increases expression | ISO | Celf5 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | dorsomorphin | multiple interactions | ISO | CELF5 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | ethanol | multiple interactions | ISO | Celf5 (Mus musculus) | 6480464 | Ethanol affects the expression of and affects the splicing of CELF5 mRNA | CTD | PMID:30319688 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of CELF5 mRNA | CTD | PMID:30307764 | folic acid | decreases expression | ISO | Celf5 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of CELF5 mRNA | CTD | PMID:25629700 | fulvestrant | multiple interactions | ISO | CELF5 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CELF5 gene | CTD | PMID:31601247 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of CELF5 mRNA | CTD | PMID:33387578 | Licochalcone B | increases expression | ISO | CELF5 (Homo sapiens) | 6480464 | licochalcone B results in increased expression of CELF5 mRNA | CTD | PMID:33647349 | mercury dibromide | decreases expression | ISO | CELF5 (Homo sapiens) | 6480464 | mercuric bromide results in decreased expression of CELF5 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | ISO | CELF5 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CELF5 mRNA | CTD | PMID:27188386 | methapyrilene | decreases methylation | ISO | CELF5 (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of CELF5 intron | CTD | PMID:30157460 | methylmercury chloride | decreases expression | ISO | CELF5 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of CELF5 mRNA | CTD | PMID:28001369 | methylparaben | increases expression | ISO | CELF5 (Homo sapiens) | 6480464 | methylparaben results in increased expression of CELF5 mRNA | CTD | PMID:17121429 | ozone | multiple interactions | ISO | Celf5 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CELF5 mRNA | CTD | PMID:27106289 and PMID:34911549 | p-chloromercuribenzoic acid | decreases expression | ISO | CELF5 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of CELF5 mRNA | CTD | PMID:26272509 | p-chloromercuribenzoic acid | multiple interactions | ISO | CELF5 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CELF5 mRNA | CTD | PMID:27188386 | panobinostat | decreases expression | ISO | CELF5 (Homo sapiens) | 6480464 | panobinostat results in decreased expression of CELF5 mRNA | CTD | PMID:26272509 | panobinostat | multiple interactions | ISO | CELF5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CELF5 mRNA | CTD | PMID:27188386 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CELF5 mRNA | CTD | PMID:33387578 | phenylmercury acetate | decreases expression | ISO | CELF5 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of CELF5 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | CELF5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CELF5 mRNA | CTD | PMID:27188386 | propanal | increases expression | ISO | CELF5 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of CELF5 mRNA | CTD | PMID:26079696 | resveratrol | multiple interactions | ISO | CELF5 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of CELF5 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | CELF5 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | CELF5 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of CELF5 mRNA | CTD | PMID:25895662 | tetraphene | multiple interactions | ISO | Celf5 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CELF5 mRNA | CTD | PMID:27858113 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of CELF5 mRNA | CTD | PMID:23411599 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CELF5 mRNA | CTD | PMID:34492290 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of CELF5 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | CELF5 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of CELF5 mRNA | CTD | PMID:24935251 | trichostatin A | multiple interactions | ISO | CELF5 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CELF5 mRNA | CTD | PMID:27188386 | trichostatin A | decreases expression | ISO | CELF5 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of CELF5 mRNA | CTD | PMID:24935251 and PMID:26272509 | triptonide | increases expression | ISO | Celf5 (Mus musculus) | 6480464 | triptonide results in increased expression of CELF5 mRNA | CTD | PMID:33045310 | tris(2-butoxyethyl) phosphate | affects expression | ISO | CELF5 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of CELF5 mRNA | CTD | PMID:29024780 | valproic acid | affects expression | ISO | CELF5 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CELF5 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | CELF5 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CELF5 mRNA | CTD | PMID:19101580 more ... | valproic acid | decreases expression | ISO | CELF5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CELF5 mRNA | CTD | PMID:28001369 | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of CELF5 mRNA | CTD | PMID:29427782 | |